Navigation Links
Avanir Pharmaceuticals to Participate in Citi 2012 Global Health Care Conference
Date:2/21/2012

ALISO VIEJO, Calif., Feb. 21, 2012 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (Nasdaq: AVNR) today announced that company management will participate in the Citi 2012 Global Health Care Conference.

  • Citi 2012 Global Health Care Conference
    • The Waldorf Astoria Hotel, New York, NY
    • Wednesday, February 29, 2012
    • 9:00 a.m. ET

A live webcast and 30-day archive of this presentation will be available at http://ir.avanir.com.

About Avanir Pharmaceuticals, Inc.

Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit www.avanir.com.

AVANIR® is a registered trademark owned by Avanir Pharmaceuticals, Inc.

©2012 Avanir Pharmaceuticals, Inc. All Rights Reserved.

Avanir Investor & Media Contact
Ian Clements, PhD
ir@avanir.com
+1 (949) 389-6700


'/>"/>
SOURCE Avanir Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Avanir Pharmaceuticals to Present Data at MS-Focused ECTRIMS Annual Meeting
2. Avanir Pharmaceuticals to Present at the Jefferies 2011 Global Healthcare Conference
3. AVANIR Pharmaceuticals Announces Proposed Public Offering of Common Stock
4. AVANIR to Present at the Canaccord Genuity Growth Conference
5. AVANIR to Present at the Wedbush Life Sciences Conference
6. Swedish Bactiguard to Enter Into an Exclusive Distribution Agreement With Cadila Pharmaceuticals
7. BioDelivery Sciences Receives Patent Allowance Triggering $15 Million Milestone Payment from Endo Pharmaceuticals
8. Questcor Pharmaceuticals to Present at the Leerink Swann Global Healthcare Conference on February 16, 2012
9. Plaintiff Sales Representatives and Novartis Pharmaceuticals Corporation Resolve Class Action Wage and Hour Claims
10. MAP Pharmaceuticals Appoints W. James OShea to Board of Directors
11. Inovio Pharmaceuticals to Present at Noble Financial 8th Annual Equity Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... (PRWEB) January 22, 2015 Crystal Diagnostics (CDx) ... that it has received AOAC-PTM Certifications for the six non-O157 ... and O145; collectively referred to as STEC or the “Big-6”) ... colony forming unit (cfu) per 325 g of raw ground ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 zFlo Motion ... pleased to announce an exciting product from a new partner. ... analysis solutions over the past 15 years, with offerings in ... recently, their 3D IMU system (inertial measurement unit), iSen, is ...
(Date:1/22/2015)... Controlled Substance Compliance Services (CSCS), a project managed ... legal requirements around using controlled substances in pharmaceutical research, ... their international operations expand and become increasingly complex, large ... a result of the first phase of the CSCS ...
(Date:1/22/2015)... 2015 Diagenode, Inc., a leading ... Bioruptor® and complete solutions for epigenetics research, recently ... alleviating the need for manual processing. The new ... ChIP of histones or transcription factors and a ...
Breaking Biology Technology:Crystal Diagnostics Awarded AOAC-PTM Accreditation for the Rapid Detection of “Big 6” E.coli Food Pathogens 23D Motion Capture Just Got Easy 2Global Compliance Service for Controlled Substances to Expand to China 2Diagenode Launches Unique Semi-Automated Solution for Chromatin Immunoprecipitation 2
... by allowing for diversity of research,approaches while also encouraging sharing of IP, ... ... to result from reduced complexity, elimination of ... be maintained; South San Francisco,site to operate as an independent research and ...
... ev3 Inc. (Nasdaq:,EVVV) will release its 2008 second quarter ... regular market trading hours., The company will host ... a.m. Central Time (8:30 a.m. Eastern Time). ev3 management ... followed by a,question and answer session., The conference ...
... Apo-Al/HDL drug to be highlighted, TSX Exchange ... Resverlogix Corp.,("Resverlogix" or the "Company") (TSX:RVX) is pleased ... in an article titled,"Emerging Antidyslipidemic Drugs", which appears ... Drugs, a well respected scientific journal for,the pharmaceutical ...
Cached Biology Technology:Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash 2Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash 3Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash 4Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash 5Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash 6Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash 7Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash 8Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash 9Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash 10Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash 11Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash 12ev3 Inc. to Report 2008 Second Quarter Financial Results and Host Conference Call on August 1, 2008 2Resverlogix's Lead Drug Featured in Key Scientific Publication 2
(Date:1/22/2015)... 9, 2015 Valid S.A. ("Company") (BM&FBOVESPA: VLID3 ON), is ... the State of Washington,s Department of ... enrollment and central issuance system for driver,s licenses and identification ... project planning and development will start in January 2015, with ...
(Date:1/22/2015)... N.C. , Jan. 16, 2015  A man-made form ... memory and other mental capabilities in adults with mild ... pilot study led by researchers at Wake Forest Baptist ... adults diagnosed with amnesic mild cognitive impairment (MCI) or ...
(Date:1/22/2015)... and Markets ( http://www.researchandmarkets.com/research/wxdglm/global_wearable ) has ... Technologies Market and Applications, Opportunities, Industry Analysis, Segmentation, ... report to their offering. , ... be worn on the user,s body and have ...
Breaking Biology News(10 mins):Valid USA Signs Contract For Washington Driver's License Issuance 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3Global Wearable Technologies Market and Applications, Opportunities, Industry Analysis, Segmentation, Size, Growth, Share, Overview, Trends and Forecast 2014-2020 2
... The Wistar Institute shows how our cells create alternate versions ... genes are associated with multiple gene promoters, the researchers say, ... gene, for example, can be made with the same genetic ... Research, available online now, show how genes are read in ...
... Networks of biologically-connected marine protected areas need to be ... of marine fish larvae that take them from one ... Research published today in the international journal Oecologia sheds ... their larval stages, important information for the effective design ...
... American Association for Cancer Research has been the premier ... This year, Elizabeth H. Blackburn, Ph.D., the immediate ... laureate, will chair the Second AACR Conference on Frontiers ... research leaders from across the globe to encourage and ...
Cached Biology News:Multiple 'siblings' from every gene: Alternate gene reading leads to alternate gene products 2Multiple 'siblings' from every gene: Alternate gene reading leads to alternate gene products 3Data revealing migrations of larval reef fish vital for designing networks of marine protected areas 2
TEMPLIPHI HT SEQ AMPL KIT, 1 EA. Category: Sequencing Template Amplification....
... Vybrant Apoptosis Assay Kit #4 ... that occur in the permeability of cell ... both YO-PRO-1 and propidium iodide nucleic acid ... plasma membranes of apoptotic cells and labels ...
Request Info...
5-bromo-4-chloro-3-indolyl b -D-galactopyranoside (X-Gal)...
Biology Products: